Beta-blockers exhibit diverse pharmacological properties beyond beta-adrenoceptor blockade, which may influence their clinical utility and side effect profiles.
No takes yet. Share an insight, caveat, or question.
These pleiotropic effects may drive differential outcomes and tolerability; leaves open whether they should guide agent selection.
Kurt Stoschitzky (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: